- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
November 26, 2024
From Benzinga
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Eli Lilly Stock Is Rising Tuesday: What's Going On?
November 26, 2024
From Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
From Motley Fool
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
November 23, 2024
Tickers
LLY
From Motley Fool
Here's How Much You Would Need to Invest in This Unstoppable Vanguard ETF Today to Grow Your Portfolio to $1 Million or More by Retirement
November 23, 2024
From Motley Fool
2 Incredible Growth Stocks to Buy With $1,000 Right Now
November 23, 2024
From Motley Fool
Investing in Pharma Stocks? Check These 3 Things First
November 22, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
November 21, 2024
Tickers
LLY
From Motley Fool
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Is It Time to Sell Eli Lilly and Pfizer Stocks?
November 20, 2024
From Motley Fool
From Benzinga
From Benzinga
The Smartest Megacap Growth ETF to Buy With $500 Right Now
November 19, 2024
From Motley Fool
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
November 18, 2024
From Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
November 18, 2024
From Motley Fool
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
November 17, 2024
Tickers
LLY
From Motley Fool
From Benzinga
Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now
November 17, 2024
From Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
November 16, 2024
From Motley Fool
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
From Benzinga
From Motley Fool
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.